Fluorometric determination of total retinyl esters in triglyceride-rich lipoproteins

Clinical Chemistry

Volumn 44, Issue 7, 1998, Pages 1459-1465

  Orth, Matthias ^a,b   Hanich, Monika ^b   Kröning, Gerd ^a   Porsch Özcürümez, Mustafa ^a   Wieland, Heinrich ^b   Luley, Claus ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHYLOMICRON; RETINOL ESTER; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; FLUORESCENCE ANALYSIS; FLUOROMETRY; GEL PERMEATION CHROMATOGRAPHY; GENETIC DISORDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID ANALYSIS; LIPOPROTEIN METABOLISM; ULTRACENTRIFUGATION;

EID: 0031861221     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.7.1459     Document Type: Article

References (21)

1. Floren CH, Albers JJ, Bierman EL. Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cells. Biochim Biophys Acta 1981;663:336-49.
2. Floren CH, Chait A, Uptake of chylomicron remnants by the native LDL receptor in human monocyte-derived macrophages. Biochim Biophys Acta 1981;665:608-11.
3. Van Lenten BJ, Fogelman AM, Jackson RL, Shapiro S, Haberland ME, Edwards PA. Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages. J Biol Chem 1985;260:8783-8.
4. Prior JT, Kurtz DM, Ziegler DD. The hypercholesterolemic rabbit. An aid to understanding atherosclerosis in man? Arch Pathol 1961; 71:672-84.
5. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Goldberg IJ, Steinberg D, Witztum JL. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 1991;88:10143-7.
6. Proctor SD, Mamo JC. Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins. Coron Artery Dis 1996;7:239-45.
7. Mahley RW, Weisgraber KH, Innerarity TL, Rail SC Jr. Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism. JAMA 1991;265:78-83.
8. Havel RJ. Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol 1994;5:102-9.
9. Mack WJ, Krauss RM, Hodis HN. Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression. Arterioscler Thromb Vase Biol 1996;16:697-704.
10. Hazzard WR, Bierman EL. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia). Metabolism 1976; 25:777-801.
11. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987;80:1571-7.
12. Cohn JS, Johnson EJ, Millar JS, Cohn SD, Milne RW, Marcel YL, et al. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 1993;34:2033-40.
13. Boerwinkle E, Brown S, Sharrett AR, Heiss G, Patsch W. Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet 1994; 54:341-60.
14. Reznik Y, Pousse P, Herrou M, Morello R, Mahoudeau J, Drosdowsky MA, et al. Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetic patients; influence of apolipoprotein E polymorphism. Metabolism 1996;45: 63-71.
15. Lopez-Miranda J, Ordovas JM, Ostos MA, Marin C, Jansen S, Salas J, et al. Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus. Arterioscler Thromb Vase Biol 1997;17:1765-73.
16. Norum KR, Blomhoff R. McCollum Award Lecture, 1992: Vitamin A absorption, transport, cellular uptake, and storage. Am J Clin Nutr 1992;56:735-44.
17. Bubb FA, Murphy GM. Determination of serum phytofluene and retinol. Clin Chim Acta 1973;48:329-34.
18. Orth M, Wahl S, Hanisch M, Friedrich I, Wieland H, Luley C. Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype. Biochim Biophys Acta 1996; 1303:22-30.
19. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
20. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991;11:653-62.
21. Brown SA, Chambless LE, Sharrett AR, Gotto A Jr, Patsch W. Postprandial lipemia: reliability in an epidemiologic field study. Am J Epidemiol 1992;136:538-45.